checkAd

    EQS-Adhoc  790  0 Kommentare LifeWatch AG: Acquisition of FlexLife Health Inc., an INR monitoring company co-founded by the Cleveland Clinic


    EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Acquisition
    LifeWatch AG: Acquisition of FlexLife Health Inc., an INR monitoring
    company co-founded by the Cleveland Clinic

    10.11.2015 / 07:00
    Release of an ad hoc announcement pursuant to Art. 53 KR.
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------

    LifeWatch(R) acquires FlexLife Health Inc., an INR monitoring company
    co-founded by the Cleveland Clinic

    Zug/Switzerland, November 10, 2015 - LifeWatch(R) AG (SIX Swiss Exchange:
    LIFE), a leading developer and provider of medical solutions and remote
    diagnostic monitoring services in the digital health market, is pleased to
    announce the acquisition of FlexLife Health Inc., a company offering remote
    patient monitoring services in the area of coagulation measurement, by its
    subsidiary, LifeWatch Services Inc.

    FlexLife was founded in 2012 by the Cleveland Clinic Foundation and ZIN
    Technologies, Inc. (a NASA partner for health in space) to offer home
    monitoring solutions for INR (blood clotting) measurement. FlexLife offers
    INR monitoring services via a proprietary web-based digital health platform
    that is superior to all other current service offerings in the market.
    Monitoring of the INR is essential for patients taking drugs like Warfarin
    (an oral anticoagulant), which pose a risk of bleeding or clotting if
    dosing is not properly monitored.

    LifeWatch's electrophysiologist and cardiologist relationship base have
    already expressed a deep interest in remote monitoring of INR for their
    patients, since the main cause of a clinical arrhythmia, detected by
    LifeWatch's existing cardiac devices, is atrial fibrillation for which
    Warfarin is a common treatment option. Dr. Stephan Rietiker, CEO of
    LifeWatch, stated: "I am excited about this acquisition, particularly since
    Warfarin and similar generic anti-coagulants are the most commonly
    prescribed ant-coagulant medications in the U.S. The FlexLife product
    complements well our existing cardiac monitoring business and will allow us
    to provide doctors and their patients needing INR therapy due to atrial
    arrhythmias with a unique and easy-to-use product that will improve patient
    quality of life."

    LifeWatch will integrate this business into its existing operations to
    benefit from synergy effects (reimbursement, distribution, etc.) and
    profitably grow the business over the next few years. LifeWatch expects to
    commence activities already in December this year with a full launch in the
    U.S. at the beginning of 2016. The parties have agreed to keep the terms of
    the transaction confidential.
    Seite 1 von 3


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc LifeWatch AG: Acquisition of FlexLife Health Inc., an INR monitoring company co-founded by the Cleveland Clinic EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Acquisition LifeWatch AG: Acquisition of FlexLife Health Inc., an INR monitoring company co-founded by the Cleveland Clinic 10.11.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. …